Mohamed R El-Shanshory
Overview
Explore the profile of Mohamed R El-Shanshory including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussein M, Al-Zaban M, Mahmoud Y, Al-Doaiss A, Bahshwan S, El-Dougdoug K, et al.
Saudi J Biol Sci
. 2024 Jul;
31(8):104031.
PMID: 38946847
Human Rotavirus (HRV) is the causative pathogen of severe acute enteric infections that cause mortality among children worldwide. This study focuses on developing a new and effective treatment for rotavirus...
2.
M Bahlol H, Khalil S, El-Shanshory M, Salem M
Iran J Immunol
. 2024 Jun;
21(2):176-183.
PMID: 38943529
Hematopoietic stem cell transplantation (HSCT) is the only curative therapy for β-thalassemia major in children. However, it often induces graft-versus-host-disease (GVHD), which is associated with complications. In the present study,...
3.
Ibrahim H, Zakaria S, El-Batch M, El-Shanshory M, Alrayes Z, Kabel A, et al.
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289866
Background: Atherosclerosis represents one of the major causes of morbidity in children with β-thalassemia major (β-TM). Aim: This study was designed to investigate SIRT1-FOXO1 signaling in β-TM children and their...
4.
El-Shanshory M, Sherief L, Yahia S, Ragab S, Mansour A, Hassab H, et al.
Curr Pediatr Rev
. 2022 Jun;
19(2):203-209.
PMID: 35748556
Subjects And Methods: A cross-sectional multicenter study was carried out on 4320 randomly selected students from four governorates of the Nile Delta region, Egypt. All patients were to be tested...
5.
El-Shanshory M, Sherief L, Hassab H, Ragab S, Yahia S, Mansour A, et al.
J Egypt Public Health Assoc
. 2021 Oct;
96(1):27.
PMID: 34633587
Background: Screening of β thalassemia among close relatives is more feasible in highly prevalent countries with limited resources. The purpose of this study is to determine the prevalence of β...
6.
Rowisha M, El-Shanshory M, El-Hawary E, Ahmed A, Altoraky S
Stem Cell Investig
. 2020 Apr;
7:5.
PMID: 32309419
Background: The achievement of optimal number of CD34 umbilical cord stem cells is essential for successful umbilical cord stem cell transplantation. So the aim of this study was to assess...
7.
Salem M, El-Shanshory M, Abdou S, Attia M, Sobhy S, Zidan M, et al.
Immunopharmacol Immunotoxicol
. 2018 Feb;
40(2):158-167.
PMID: 29388481
Introduction: Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The precise mechanism behind the relapse in this disease is not clearly known. One possible mechanism could...
8.
El-Shanshory M, Kabbash I, Soliman H, Nagy H, Abdou S
Trans R Soc Trop Med Hyg
. 2013 Jan;
107(4):224-8.
PMID: 23343507
Background: Transfusion dependant patients are at a higher risk of acquiring bloodborne infections even under conditions of safe transfusion. This study was designed to determine sero-prevalence of hepatitis C infection...
9.
El-Shitany N, Tolba O, El-Shanshory M, El-Hawary E
J Card Fail
. 2012 Aug;
18(8):607-13.
PMID: 22858075
Background: Adriamycin (ADR) is a potent chemotherapeutic agent widely used in the treatment of childhood acute lymphoblastic leukemia (ALL); its clinical use is limited owing to its marked cardiotoxicity. The...
10.
El-Sharnouby J, Abou El-Enein A, El Ghannam D, El-Shanshory M, Hagag A, Yahia S, et al.
J Oncol Pharm Pract
. 2009 Dec;
16(3):179-88.
PMID: 19969624
Multidrug resistance (MDR) is a phenomenon by which cells become resistant to unrelated chemotherapeutic agents. The prognostic value that lung resistance protein (LRP) and multidrug resistance-related protein 1 (MRP1) have...